Tharimmune, Inc. (THAR) Stock Analysis
DELISTED 2026
What happened to Tharimmune, Inc. (THAR) stock?
Tharimmune, Inc. (THAR) no longer trades on public markets. It was delisted in February 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- February 2026
- Last recorded price (historical):
- $3.54 (last quote on record before the February 2026 delisting; historical, not a current quote)
Market cap $140M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Tharimmune, Inc. (THAR). Tharimmune, Inc. is a clinical-stage biotechnology company focused on developing therapeutic candidates for rare, inflammatory, and oncologic diseases. Their pre-clinical immuno-oncology pipeline includes TH104, TH3215, TH0059, and TH1940.
Last analyzed: May 7, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Tharimmune, Inc. (THAR) Healthcare & Pipeline Overview
More about this archive record
Can I still buy THAR shares?
No. THAR stopped trading on public markets in February 2026, so the shares are not available through a broker. Anything you see quoted for THAR elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before THAR stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Tharimmune, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.